TrialJournal of gynecologic oncology2026

Neoadjuvant therapy of iparomlimab and tuvonralimab combined with chemotherapy-extenuated for locally advanced cervical cancer (NICE-CC): an investigator-initiated, multicentre, open-label, phase II trial.

Jie Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.